A false claim is circulating online that the European Medicines Agency (EMA) has acknowledged that mRNA vaccines have not ...

The European orphan drug market is growing and is already comparable in size and scope to the US market. The European Union ...

The European Union's medicines regulator on Friday reiterated its positive recommendation for Eisai and Biogen's Alzheimer's ...

Getting patients access to treatments they need – without which they will die – is the ‘biggest burden of my life’, says Prof ...

From a historic vaccine approval to a $50bn investment reshaping US drug manufacturing, February brought major pharma news to ...

Leqembi’s application now moves forward to the European Commission, which will issue a formal verdict for the injection that ...

FYB202/Otulfi ® (ustekinumab-aauz), a biosimilar to Stelara®, launched in the United States and the European Union FYB202/Otulfi ® is now commercially available in both subcutaneous and intravenous ...

Following a flurry of activity at this month’s meeting of the European Medicines Agency’s Committee for Medicinal Products ...

Medicines account for more than 13 per cent – about €3.3 billion – of a health budget that is permanently under strain. That ...

Following a year of strategic expansion, European medicine-related companies are advancing their operations in Vietnam.